Delivery Order SPE2DB20D9127-SPE2DB25FPRD7
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 28, 2025, by the Defense Logistics Agency (DLA) for the supply of Jakafi 15 mg tablets (60 count). This $24.0K firm fixed-price delivery order, which was completed on July 29, 2025, carries no set-aside designation and represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 15 mg tablets (60-count units) with a ceiling value of $11,999.80. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,293.60 on August 11, 2025, for the supply of Jakafi 5 mg tablets (60-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain under the SPE2DB Indefinite Delivery Contract program. The...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,231.30 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order is expected to be completed by July 31, 2025, and represents a continuation of the company's significant role as a federal pharmaceutical supplier. The award carries no set-aside...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRD7Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through November 2026. The delivery order carries no set-aside designation, reflecting the contractor's competitive position as a woman-owned small business in federal pharmaceutical procurement. The place of performance is listed as Park Ridge, Illinois, where the company maintains its operations. This award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, specifically supporting the Department of Defense healthcare system. Jakafi (ruxolitinib) is a prescription medication used in treating certain blood disorders and inflammatory conditions, underscoring the company's specialization in providing both specialty and standard pharmaceuticals to military health facilities. As a delivery order under an existing IDC vehicle, this award demonstrates the efficiency of the DLA's procurement approach, allowing for rapid fulfillment of specific pharmaceutical needs across the defense healthcare network while maintaining pre-negotiated pricing and terms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/19/25 |